133 related articles for article (PubMed ID: 9568286)
1. Synthesis and vasorelaxant activity of 2-fluoromethylbenzopyran potassium channel openers.
Takahashi T; Koga H; Sato H; Ishizawa T; Taka N; Imagawa J
Bioorg Med Chem; 1998 Mar; 6(3):323-37. PubMed ID: 9568286
[TBL] [Abstract][Full Text] [Related]
2. Effects of rubidium on responses to potassium channel openers in rat isolated aorta.
Greenwood IA; Weston AH
Br J Pharmacol; 1993 Aug; 109(4):925-32. PubMed ID: 8401946
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the vascular relaxant effects of ATP-dependent K+ channel openers on aorta and pulmonary artery isolated from spontaneously hypertensive and Wistar-Kyoto rats.
Kwan YW; To KW; Lau WM; Tsang SH
Eur J Pharmacol; 1999 Jan; 365(2-3):241-51. PubMed ID: 9988108
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
Lawson K; Barras M; Zazzi-Sudriez E; Martin DJ; Armstrong JM; Hicks PE
Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and vasorelaxant activity of 4-(cyclic amido)-2H-naphtho[1,2-b]pyrans.
Chiou WF; Li SY; Ho LK; Hsien ML; Don MJ
Eur J Med Chem; 2002 Jan; 37(1):69-75. PubMed ID: 11841876
[TBL] [Abstract][Full Text] [Related]
6. Ba2+ differentially inhibits the Rb+ efflux promoting and the vasorelaxant effects of levcromakalim and minoxidil sulfate in rat isolated aorta.
Quast U; Baumlin Y; Loffler C
Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 353(1):86-93. PubMed ID: 8750921
[TBL] [Abstract][Full Text] [Related]
7. Effects of the potassium channel openers KRN4884 and levcromakalim on the contraction of rat aorta induced by A23187, compared with nifedipine.
Kawahara J; Izumi H; Okada Y; Izawa T
Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):460-5. PubMed ID: 8897449
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448.
Grover GJ; McCullough JR; D'Alonzo AJ; Sargent CA; Atwal KS
J Cardiovasc Pharmacol; 1995 Jan; 25(1):40-50. PubMed ID: 7723352
[TBL] [Abstract][Full Text] [Related]
9. Influence of depolarization on vasorelaxant potency and efficacy of Ca2+ entry blockers, K+ channel openers, nitrate derivatives, salbutamol and papaverine in rat aortic rings.
Magnon M; Calderone V; Floch A; Cavero I
Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):452-63. PubMed ID: 9826068
[TBL] [Abstract][Full Text] [Related]
10. Potassium channel-opening and vasorelaxant profiles of a novel compound YM099 in rat isolated portal vein and rabbit isolated aorta.
Uchida W; Hirano Y; Shirai Y; Taguchi T; Masuda N; Shibasaki K; Hirano S; Matsumoto Y; Tsuzuki R; Yanagisawa I
Arch Int Pharmacodyn Ther; 1994; 327(3):330-43. PubMed ID: 7848015
[TBL] [Abstract][Full Text] [Related]
11. The individual enantiomers of cis-cromakalim possess K+ channel opening activity.
Quast U; Villhauer EB
Eur J Pharmacol; 1993 Apr; 245(2):165-71. PubMed ID: 8491256
[TBL] [Abstract][Full Text] [Related]
12. New R/S-3,4-dihydro-2,2-dimethyl-2H-1-benzopyrans as K(ATP) channel openers: modulation of the 4-position.
Florence X; Sebille S; Tullio Pd; Lebrun P; Pirotte B
Bioorg Med Chem; 2009 Nov; 17(22):7723-31. PubMed ID: 19822435
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of the K(+)-channel openers cromakalim and minoxidil sulphate on vascular smooth muscle.
Wickenden AD; Grimwood S; Grant TL; Todd MH
Br J Pharmacol; 1991 May; 103(1):1148-52. PubMed ID: 1878752
[TBL] [Abstract][Full Text] [Related]
14. Modulation of intracellular calcium by potassium channel openers in vascular muscle.
Erne P; Hermsmeyer K
Naunyn Schmiedebergs Arch Pharmacol; 1991 Dec; 344(6):706-15. PubMed ID: 1775202
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and pharmacological evaluation of R/S-3,4-dihydro-2,2-dimethyl- 6-halo-4-(phenylaminocarbonylamino)-2H-1-benzopyrans: toward tissue-selective pancreatic beta-cell KATP channel openers structurally related to (+/-)-cromakalim.
Sebille S; Gall D; de Tullio P; Florence X; Lebrun P; Pirotte B
J Med Chem; 2006 Jul; 49(15):4690-7. PubMed ID: 16854075
[TBL] [Abstract][Full Text] [Related]
16. Cardioselective antiischemic ATP-sensitive potassium channel openers. 2. Structure-activity studies on benzopyranylcyanoguanidines: modification of the benzopyran ring.
Atwal KS; Grover GJ; Ferrara FN; Ahmed SZ; Sleph PG; Dzwonczyk S; Normandin DE
J Med Chem; 1995 May; 38(11):1966-73. PubMed ID: 7783128
[TBL] [Abstract][Full Text] [Related]
17. [Synthesis and vasorelaxant activities of benzopyran-4-one hydrazone derivatives].
Zhao SY; Huang WL; Zhang HB
Yao Xue Xue Bao; 2002 Aug; 37(8):621-5. PubMed ID: 12567776
[TBL] [Abstract][Full Text] [Related]
18. Highly potent 1,4-benzothiazine derivatives as K(ATP)-channel openers.
Cecchetti V; Calderone V; Tabarrini O; Sabatini S; Filipponi E; Testai L; Spogli R; Martinotti E; Fravolini A
J Med Chem; 2003 Aug; 46(17):3670-9. PubMed ID: 12904071
[TBL] [Abstract][Full Text] [Related]
19. Differential vasorelaxant effects of K(+)-channel openers and Ca(2+)-channel blockers on canine isolated arteries.
Iwamoto T; Nishimura N; Morita T; Sukamoto T
J Pharm Pharmacol; 1993 Apr; 45(4):292-7. PubMed ID: 8098370
[TBL] [Abstract][Full Text] [Related]
20. Smooth muscle K+ channel openers; their pharmacology and clinical potential.
Weston AH
Pflugers Arch; 1989; 414 Suppl 1():S99-105. PubMed ID: 2674897
[No Abstract] [Full Text] [Related]
[Next] [New Search]
